Hautzentrum Friedrichshain

At Hautzentrum Friedrichshain in Berlin, clinical trials focus on immune system diseases and skin and connective tissue diseases, with studies designed to improve treatment options for chronic inflammatory conditions affecting the skin.

• Atopic dermatitis research exploring new ways to reduce inflammation, itching, and flare severity
• Hidradenitis suppurativa studies evaluating therapies for moderate to severe disease control
• Prurigo nodularis trials aimed at easing itch and improving skin lesions

The site is also involved in assessing whether emerging therapies can provide better symptom relief and longer-term disease management for patients with persistent dermatologic and immune-mediated disorders.

Several trials at this research site are centered on atopic dermatitis, a common chronic skin condition that can cause intense itching, irritation, and recurring eczema. The research is intended to test new treatment approaches and measure how well they improve everyday skin symptoms.

• Atopic dermatitis studies comparing new therapies with placebo
• Eczema research focused on reducing disease severity and improving skin clearance
• Long-term safety evaluations for treatments used in adults and adolescents

These studies help build a clearer picture of treatment effectiveness and safety for people living with moderate to severe eczema.

Clinical research here also addresses hidradenitis suppurativa, a painful inflammatory skin disease that can be difficult to control. The trials are designed to determine whether newer therapies can better reduce symptoms and improve clinical response in adults with more advanced disease.

• Moderate to severe hidradenitis suppurativa treatment studies
• Inflammation control and symptom reduction research
• Clinical response assessments for emerging therapies

By examining how patients respond over time, the studies aim to support more effective care for this chronic and often disruptive condition.

Another important area of research at Hautzentrum Friedrichshain involves prurigo nodularis, a condition marked by severe itching and skin nodules. The trials are focused on testing treatments that may ease itch, improve skin lesions, and enhance quality of life.

• Prurigo nodularis symptom control studies
• Itch reduction and lesion improvement research
• Ongoing safety follow-up for long-term treatment use

This work supports the search for better options for patients whose symptoms remain difficult to manage with standard care.

The site also runs trials in seasonal allergic rhinitis and rhinoconjunctivitis, conditions triggered by birch pollen and other seasonal allergens. These studies aim to evaluate whether new allergy treatments can improve symptom control during allergy season.

• Birch pollen-induced seasonal allergic rhinitis research
• Rhinoconjunctivitis symptom relief studies
• Effectiveness testing for allergy-focused therapies

By measuring how well participants respond, the trials contribute to better management of common seasonal allergy symptoms.